Elevation Wealth Partners
RVMD icon

Elevation Wealth Partners’s Revolution Medicines RVMD Stock Holding History

Elevation Wealth Partners’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.08K Hold
15
– – ﹤0.01% 1186
2026
Q2 		$2.81K Buy
+15
New +$2.19K ﹤0.01% 1143

Other funds holding RVMD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Loftus Peak
Loftus Peak Sydney, Australia $781M AUM
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Elevation Wealth Partners's RVMD Position: Q3 2026 in Review

Elevation Wealth Partners held its Revolution Medicines (RVMD) position steady in Q3 2026 at 15 shares worth $3.08K. The position accounts for ﹤0.01% of the portfolio, ranked #1186.

Elevation Wealth Partners first reported a position in RVMD in Q2 2026 and has held it in 2 quarters since. 224 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Elevation Wealth Partners held 15 shares of Revolution Medicines worth $3.08K as of Q3 2026.
  • Elevation Wealth Partners left its Revolution Medicines share count unchanged in Q3 2026.
  • Revolution Medicines made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #1186 holding.
  • Elevation Wealth Partners first reported a position in Revolution Medicines in Q2 2026 and has held it in 2 quarters since.
  • 224 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.